A study of vitamin D status in children with tuberculosis in Peterborough, United Kingdom

Molla Imaduddin Ahmed, Mona Aslam

Abstract


Background: We aimed to compare the prevalence of vitamin D deficiency and insufficiency in children with active or latent tuberculosis with the control population.

Methods: This was a retrospective case control study and included 34 patients with evidence of exposure to tuberculosis and 34 controls reviewed at Peterborough city hospital from October 2011 to September 2013, who were matched with regards to age, gender and ethnicity. All patients had blood investigations, chest X-ray, Quantiferon Gold and Mantoux done at the time of review along with serum 25-hydroxyvitamin D concentrations in serum.

Results: 73.6% of patients with Childhood Tuberculosis and 47.1 % of controls had low Vitamin D levels (deficiency and insufficiency). The median vitamin D level in children with tuberculosis was 34.75 nmol/l and in controls was 52.8 nmol/l. Patients older than 12 years of age had significantly lower serum 25-hydroxyvitamin D concentrations than those patients younger than 5 year of age. Gender, ethnicity, BMI, BCG status, serum calcium, serum phosphate and alkaline phosphatase had no significant correlation with vitamin D concentration in patients and controls.

Conclusions: The present study demonstrated that children with evidence of exposure to Tuberculosis were more likely to be associated with lower levels of vitamin D than control population. Larger multi-centric randomized controlled trials are needed to prove the association between vitamin D and Tuberculosis. The association between low levels of vitamin D and tuberculosis suggests investigation for vitamin D deficiency in all children diagnosed with Tuberculosis and supplementation of these children with vitamin D.  


Keywords


Tuberculosis, Vitamin D deficiency and insufficiency

Full Text:

PDF

References


Centre for Infectious Disease Surveillance and Control. Tuberculosis in the UK: report HPA. In: CIDSC, eds. Tuberculosis Section. England: Public Health; August 2013.

Chapman HT. On the use of cod-liver oil in diseases of the bones and joints, in consumption and in other maladies attended by great emaciation. Pharm Trans. 1849;1:1-16.

Mayer E. Heliotherapy of tuberculosis. Ann Int Med. 1938;11:1856-60.

Rockett KA, Brookers R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase andsuppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun. 1998;66:5314-21.

Liu PT, Modlin RL. Human macrophage host defence against Mycobacterium tuberculosis. Curr Opin Immunol. 2008;20:371-6.

Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.

Martineau AR, Wilkinson KA, Newton SM, Floto Andres, Norman Anthony, Skolimowska Keira, et al. IFN-gamma and human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol. 2007;178:7190-8.

Liu PT, Modlin RL. Human macrophage host defence against Mycobacterium tuberculosis. Curr Opin Immunol. 2008;20(4):371-6.

Yuk JM, Shin DM, Lee HM, Chul-Su Yang, Hyo Sun Jin, Kwang-Kyu Kim, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe. 2009;6(3):231-3.

Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37:113-9.